Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,791 | -44,582 | -42,771 | -31,793 | -24,122 |
| Depreciation Amortization | 214 | 292 | 192 | 148 | 150 |
| Other Working Capital | -3,127 | -1,726 | 3,476 | 1,684 | 199 |
| Other Operating Activity | 1,586 | -1,568 | 6,725 | 4,738 | 1,205 |
| Operating Cash Flow | $-23,118 | $-47,583 | $-32,377 | $-25,222 | $-22,569 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -104 | -864 | -226 | -141 |
| Investing Cash Flow | $-6 | $-104 | $-864 | $-226 | $-141 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,032 | 61,411 | 22,940 | N/A | 1,249 |
| Other Financing Activity | 0 | 0 | 0 | 9,611 | 0 |
| Financing Cash Flow | $13,032 | $61,411 | $22,940 | $9,611 | $1,249 |
| Beginning Cash Position | 23,289 | 9,565 | 19,866 | 35,704 | 57,165 |
| End Cash Position | 13,196 | 23,289 | 9,565 | 19,866 | 35,704 |
| Net Cash Flow | $-10,093 | $13,724 | $-10,301 | $-15,838 | $-21,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,118 | -47,583 | -32,377 | -25,222 | -22,569 |
| Capital Expenditure | -6 | -104 | -864 | -226 | -141 |
| Free Cash Flow | -23,124 | -47,687 | -33,241 | -25,448 | -22,710 |